Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Su

Showing results (41-50 of 60) with videos related to

Pageof 6
Sort By:
Circulation|October 13, 2006
Potent reduction of apolipoprotein B and low-density lipoprotein cholesterol by short-term administration of an antisense inhibitor of apolipoprotein BJohn J P Kastelein, Mark K Wedel, Brenda F Baker, et al.
European Heart Journal|May 20, 2011
Efficacy of apolipoprotein B synthesis inhibition in subjects with mild-to-moderate hyperlipidaemiaFatima Akdim, Diane L Tribble, JoAnn D Flaim, et al.
BMC Dermatology|April 5, 2012
A phase I study of daily treatment with a ceramide-dominant triple lipid mixture commencing in neonatesAdrian J Lowe, Mimi Lk Tang, Shyamali C Dharmage, et al.
The Australasian Journal of Dermatology|November 11, 2011
Autosomal dominant bullous dermolysis of the newborn associated with a heterozygous missense mutation p.G1673R in type VII collagenJohn Frew, Shueh W Lim, Alfred Klausseger, et al.
The American Journal of Cardiology|May 11, 2010
Effect of mipomersen, an apolipoprotein B synthesis inhibitor, on low-density lipoprotein cholesterol in patients with familial hypercholesterolemiaFatima Akdim, Maartje E Visser, Diane L Tribble, et al.
Pediatric Allergy and Immunology : Official Publication of the European Society of Pediatric Allergy and Immunology|March 17, 2017
Age at onset and persistence of eczema are related to subsequent risk of asthma and hay fever from birth to 18 years of ageAdrian J Lowe, Bianca Angelica, John Su, et al.
MMWR. Morbidity and Mortality Weekly Report|February 25, 2021
First Month of COVID-19 Vaccine Safety Monitoring - United States, December 14, 2020-January 13, 2021Julianne Gee, Paige Marquez, John Su, et al.
BMJ Open|March 15, 2019
PEBBLES study protocol: a randomised controlled trial to prevent atopic dermatitis, food allergy and sensitisation in infants with a family history of allergic disease using a skin barrier improvement strategyAdrian Lowe, John Su, Mimi Tang, et al.
Archives of Internal Medicine|October 14, 2009
Multistate outbreak of Serratia marcescens bloodstream infections caused by contamination of prefilled heparin and isotonic sodium chloride solution syringesDavid Blossom, Judith Noble-Wang, John Su, et al.
Circulation Research|April 2, 2013
Antisense oligonucleotide inhibition of apolipoprotein C-III reduces plasma triglycerides in rodents, nonhuman primates, and humansMark J Graham, Richard G Lee, Thomas A Bell, et al.
Pageof 6

Showing results (41-50 of 60) with videos related to

Sort By:
Pageof 6
Circulation|October 13, 2006
Potent reduction of apolipoprotein B and low-density lipoprotein cholesterol by short-term administration of an antisense inhibitor of apolipoprotein BJohn J P Kastelein, Mark K Wedel, Brenda F Baker, et al.
European Heart Journal|May 20, 2011
Efficacy of apolipoprotein B synthesis inhibition in subjects with mild-to-moderate hyperlipidaemiaFatima Akdim, Diane L Tribble, JoAnn D Flaim, et al.
BMC Dermatology|April 5, 2012
A phase I study of daily treatment with a ceramide-dominant triple lipid mixture commencing in neonatesAdrian J Lowe, Mimi Lk Tang, Shyamali C Dharmage, et al.
The Australasian Journal of Dermatology|November 11, 2011
Autosomal dominant bullous dermolysis of the newborn associated with a heterozygous missense mutation p.G1673R in type VII collagenJohn Frew, Shueh W Lim, Alfred Klausseger, et al.
The American Journal of Cardiology|May 11, 2010
Effect of mipomersen, an apolipoprotein B synthesis inhibitor, on low-density lipoprotein cholesterol in patients with familial hypercholesterolemiaFatima Akdim, Maartje E Visser, Diane L Tribble, et al.
Pediatric Allergy and Immunology : Official Publication of the European Society of Pediatric Allergy and Immunology|March 17, 2017
Age at onset and persistence of eczema are related to subsequent risk of asthma and hay fever from birth to 18 years of ageAdrian J Lowe, Bianca Angelica, John Su, et al.
MMWR. Morbidity and Mortality Weekly Report|February 25, 2021
First Month of COVID-19 Vaccine Safety Monitoring - United States, December 14, 2020-January 13, 2021Julianne Gee, Paige Marquez, John Su, et al.
BMJ Open|March 15, 2019
PEBBLES study protocol: a randomised controlled trial to prevent atopic dermatitis, food allergy and sensitisation in infants with a family history of allergic disease using a skin barrier improvement strategyAdrian Lowe, John Su, Mimi Tang, et al.
Archives of Internal Medicine|October 14, 2009
Multistate outbreak of Serratia marcescens bloodstream infections caused by contamination of prefilled heparin and isotonic sodium chloride solution syringesDavid Blossom, Judith Noble-Wang, John Su, et al.
Circulation Research|April 2, 2013
Antisense oligonucleotide inhibition of apolipoprotein C-III reduces plasma triglycerides in rodents, nonhuman primates, and humansMark J Graham, Richard G Lee, Thomas A Bell, et al.
Pageof 6